Miscellaneous Bone Resorption Inhibitors
*Prices reflect U.S. average retail price
Denosumab (trade names Prolia and Xgeva) is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone... Wikipedia
Manufacturer's Website: Prolia
Average retail cost: $2,402/syringe
Denosumab (trade names Prolia and Xgeva) is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone... Wikipedia
Manufacturer's Website: Xgeva
Average retail cost: $6,588/vial
Xgeva (denosumab)
This drug is no longer available as it has been discontinued by the manufacturer.